Next, we showed that hRAT-CMs increase the expression of mesenchymal markers, like desmin, N-cadherine and vimentin, in both tumor and non-tumor renal epithelial cells and that AT can stimulate the epithelial-mesenchymal transition (EMT) and therefore the metastatic capacity of cells (15). The gene discussed is CDH2; the disease is neoplasm.